CRBP

NASDAQStock

Corbus Pharmaceuticals Holdings, Inc.

$9.38-0.21 (-2.19%)

52-Week Range

$4.92
$19.36

Key Stats

Market Cap

P/E Ratio

Dividend Yield

Beta

2.91

Volume

108.3K

Avg Volume

254.2K

Performance

1M

+26.85%

3M

+1.16%

6M

-6.62%

YTD

+21.86%

1Y

+37.79%

3Y

+66.78%

5Y

-85.34%

Price Chart

ETF Exposure

CRBP is held by 12 ETFs

ETFFund NameWeight
OZEMRoundhill Investments - GLP-1 & Weight Loss ETF0.40%
IWCiShares Micro-Cap ETF0.02%
STSBiShares Factors US Small Blend Style ETF0.02%
DFASDimensional - US Small Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About CRBP ETF Exposure

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $9.38. Investors can gain exposure to CRBP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CRBP, sorted by portfolio weight.